We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

The U.S. Food and Drug Administration recently approved and granted emergency use authorization or EUA for updated Covid vaccines (2024-2025 formula) from Pfizer ... appointment in advance at CVS ...

serving as a one-stop shop where they can make doctor’s appointments, find vaccines and order tests and treatments. To start, according to Pfizer’s launch announcement Tuesday, the platform ...

Additionally – given that uptake has been slow anyway for Covid-19 booster ... Pfizer/BioNTech Comirnaty price-hike is not entirely unexpected. Although the projected cost is far more than what ...

Pfizer and Valneva may have about two more years ... data from a phase 2 trial where participants had received a second booster shot a year after their first booster. The immune response and ...

In addition to the new Pfizer and Moderna boosters, Novavax also expects to have an updated vaccine on the market soon. The Associated Press contributed to this report.

Tuesday, Valneva SE (NASDAQ:VALN) and Pfizer Inc. (NYSE:PFE) released immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease ...

But even after the booster-shot argument for the stock's growth fell apart, the broader bull thesis rooted in the success of Pfizer's infectious ... convenience of one appointment to gain ...

On Thursday, the Food and Drug Administration (FDA) signed off on these updated COVID vaccines from Moderna and Pfizer ... For example, CVS is currently offering appointments for the new COVID ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...

The Pfizer and Moderna shots target a subtype ... the current variants of COVID-19." at its stores. Appointments can be made here. In CVS, doses are also available nationwide.

NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...